Trial Profile
Prevention of Recurrent Gastric or Duodenal Ulcers caused by Low-dose Aspirin with Rabeprazole (E3810) Treatment. -A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial-(Planetarium study)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Teprenone
- Indications Duodenal ulcer; Gastric ulcer; NSAID-induced ulcer
- Focus Registrational; Therapeutic Use
- Acronyms Planetarium
- Sponsors Eisai Co Ltd
- 28 Nov 2013 Results published in the Media Release.
- 28 Nov 2013 Primary endpoint 'Disease-recurrence-rate' has been met.
- 28 Nov 2013 Status changed from recruiting to completed (parent trial; NCT01397448).